Synthesis and binding affinities for 5-HT1A, 5-HT2A and 5-HT2C receptors of a series of 1-and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3-triazole derivatives

被引:18
作者
Caliendo, G
Fiorino, F
Grieco, P
Perissutti, E
Santagada, V
Albrizio, S
Spadola, L
Bruni, G
Romeo, MR
机构
[1] Univ Naples Federico II, Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy
[2] Univ Salerno, Dipartimento Sci Farmaceut, I-84080 Salerno, Italy
[3] Univ Siena, Ist Farmacol, I-53100 Siena, Italy
关键词
arylpiperazines; synthesis; 5-HT receptor; serotonin;
D O I
10.1016/S0223-5234(99)00221-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of 1- and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3-triazole derivatives (1-4) were prepared in order to obtain compounds with a high affinity and selectivity for 5-HT1A receptors. 5-HT1A, 5-HT2A and 5-MT2C affinities were determined by radioligand binding experiments and the most active compounds were also tested for binding affinities on dopaminergic D-1, D-2 and adrenergic a,, a, receptors. The modification of aromatic substituents, the length of the alkyl chain and its position on the 4-benzoyl-1,2,3-triazole ring were explored. Most of the considered compounds generally showed moderate to high affinity for the 5-HT1A receptor binding site. Three derivatives 2c, 3c and 3e bind to 5-HT1A receptors in the nanomolar range (IC50 values = 2, 7.2 and 2.6 nM respectively). The most active compound, 2c, presented a high degree of selectivity versus all considered receptors. It was found that the benzoyltriazole derivatives Ih and 4c are new selective ligands for 5-HT2A (IC50 = 89 nM) and 5-HT2C receptors (IC50 = 17 nM), respectively. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:719 / 727
页数:9
相关论文
共 20 条
[1]  
BAUMGARTEN HG, 1997, SEROTONINERGIC NEURO
[2]  
BIAGI G, 1986, FARMACO, V41, P388
[3]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[4]   Structure-affinity relationship studies on benzotriazole derivatives binding to 5-HT receptor subtypes [J].
Caliendo, G ;
Greco, G ;
Grieco, P ;
Novellino, E ;
Perissutti, E ;
Santagada, V ;
Barbarulo, D ;
Esposito, E ;
DeBlasi, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (03) :207-213
[5]   H-3-SPIROPERIDOL LABELS DOPAMINE RECEPTORS IN PITUITARY AND BRAIN [J].
CREESE, I ;
SCHNEIDER, R ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 46 (04) :377-381
[6]   SEROTONERGIC MECHANISMS IN ANXIETY [J].
EISON, AS ;
EISON, MS .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (01) :47-62
[7]   THE NEW GENERATION OF SEROTONERGIC ANXIOLYTICS - POSSIBLE CLINICAL ROLES [J].
EISON, MS .
PSYCHOPATHOLOGY, 1989, 22 :13-20
[8]   CONCEPTS FOR THE DESIGN OF 5-HT(1A) SEROTONIN AGONISTS AND ANTAGONISTS [J].
GLENNON, RA .
DRUG DEVELOPMENT RESEARCH, 1992, 26 (03) :251-274
[9]   BINDING CHARACTERISTICS OF PRAZOSIN-H-3 TO RAT-BRAIN ALPHA-ADRENERGIC RECEPTORS [J].
GREENGRASS, P ;
BREMNER, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 55 (03) :323-326
[10]   THE CENTRAL 5-HT1A RECEPTORS - PHARMACOLOGICAL, BIOCHEMICAL, FUNCTIONAL, AND REGULATORY PROPERTIES [J].
HAMON, M ;
GOZLAN, H ;
ELMESTIKAWY, S ;
EMERIT, MB ;
BOLANOS, F ;
SCHECHTER, L .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 600 :114-131